Well Lead Medical Co., Ltd. (SHA:603309)
China flag China · Delayed Price · Currency is CNY
11.49
-0.39 (-3.28%)
Jul 31, 2026, 3:00 PM CST

Well Lead Medical Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1,6551,6311,5091,3881,3631,119
Revenue Growth
4.85%8.07%8.76%1.79%21.88%-1.07%
Gross Profit
716.98720.15662.88625.1578.37471.76
Operating Income
270.27285.86254.9234.42197.13149.16
Net Income
57.2576.33219.39192.49166.57106.09
Earnings Per Share
0.200.260.750.660.570.41
EPS Growth
-75.47%-65.33%13.64%15.79%39.02%-30.51%

Revenue by Geography

Fiscal YearFY 2025
Period EndingDec '25
China
685.8
Overseas
919.31
Total
1,605

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
434.6519.05480.26446.95703.96634.77
Total Debt
619.92622.38508.2397.08260244.62
Net Cash (Debt)
-185.32-103.33-27.9449.87443.96390.15
Net Cash Growth
----88.77%13.79%1309.49%
Net Cash Per Share
-0.64-0.35-0.100.171.521.51

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
456.63330.26306.26222.51391.13187.28
Capital Expenditures
-210.2-206.15-315.73-357.89-181.38-109.28
Free Cash Flow
246.44124.11-9.47-135.38209.7578
Free Cash Flow Growth
----168.90%-42.63%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
43.33%44.15%43.92%45.04%42.42%42.18%
Operating Margin
16.33%17.52%16.89%16.89%14.46%13.33%
Pretax Margin
6.57%7.99%17.43%17.10%15.08%12.54%
Profit Margin
3.46%4.68%14.54%13.87%12.22%9.49%
FCF Margin
14.89%7.61%-0.63%-9.75%15.38%6.97%

Dividends

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.6000.5000.5000.5000.3400.135
Dividend Per Share Growth
0%0%0%47.06%151.85%-32.50%
Dividend Yield
5.22%3.82%4.52%3.96%1.95%0.99%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
58.5351.9715.9921.6735.1839.36
Forward PE
10.6413.7313.2419.7680.3080.30
P/FCF Ratio
13.6131.96--27.9453.53
PS Ratio
2.032.432.333.014.303.73